FrancophonIA/ELRC3.0 huggingface dataset:
English: Hypertensive patients with type 2 diabetes and renal disease The effects of irbesartan both on renal and cardiovascular events were not uniform across all subgroups, in an analysis carried out in the study with patients with advanced renal disease.
Icelandic: Háþrýstingssjúklingar með sykursýki af gerð 2 og nýrnasjúkdóm Áhrif irbesartans, bæði á sjúklinga með nýrna- og hjarta- og æðasjúkdóma, voru ekki þau sömu hjá öllum undirhópum við greiningu sem gerð var í rannsókninni á sjúklingum með langt genginn nýrnasjúkdóm.
English: While this is not documented with Ifirmasta, a similar effect should be anticipated with angiotensin-II receptor antagonists.
Icelandic: Þótt þetta hafi ekki komið fram við notkun Ifirmasta má búast við svipuðum áhrifum með angíótensín-II blokkum.
English: Ifirmasta prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower.
Icelandic: Ifirmasta hindrar bindingu angíótensín-II við þessa viðtaka þannig að það slaknar á æðum og blóðþrýstingur lækkar.
English: Based on experience with the use of other medicinal products that affect the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e.g. heparin) may lead to increases in serum potassium and is, therefore, not recommended (see section 4.4).
Icelandic: Með hliðsjón af notkun annarra lyfja sem hafa áhrif á renín-angíótensín kerfið, getur samtímis notkun kalíumsparandi þvagræsilyfja, kalíumuppbótar, saltuppbótar sem inniheldur kalíum eða annarra lyfja sem auka kalíumgildi í sermi (t.d. heparín) valdið aukningu á kalíum í sermi og er því ekki ráðlögð (sjá kafla 4.4).
English: Available pharmacodynamic/toxicological data in rats have shown excretion of irbesartan or its metabolites in milk (for details see 5.3).
Icelandic: Fyrirliggjandi upplýsingar um lyfhrif og eiturefnafræði hjá rottum sýna að irbesartan eða umbrotsefni þess skiljast út í móðurmjólk (sjá ítarlegri upplýsingar í kafla 5.3).
English: Undesirable effects where the frequency is not known are: feeling of spinning, headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles, reduced number of platelets, abnormal liver function, increased blood potassium levels, impaired renal function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis) and severe allergic reactions (anaphylactic shock).
Icelandic: Aukaverkanir þar sem tíðni er ekki þekkt eru: svimi, höfuðverkur, bragðtruflanir, suð fyrir eyrum, vöðvakrampar, verkur í liðum og vöðvum, fækkun blóðflagna, truflanir á lifrarstarfsemi, hækkuð kalíumgildi í blóði, skert nýrnastarfsemi, bólga í litlum æðum sem hefur aðallega áhrif á húð (sjúkdómur þekktur sem hvítkornasundrandi æðabólga) og veruleg ofnæmisviðbrögð (bráðaofnæmislost).
English: Other antihypertensive agents may increase the hypotensive effects of irbesartan; however Ifirmasta has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Icelandic: Önnur blóðþrýstingslækkandi lyf geta aukið blóðþrýstingslækkandi áhrif irbesartans; þó hefur samtímis gjöf Ifirmasta og annarra blóðþrýstingslækkandi lyfja eins og beta-blokka, langverkandi kalsíumgangaloka og tíazíð þvagræsilyfja reynst örugg.
English: Ifirmasta belongs to a group of medicines known as angiotensin-II receptor antagonists.
Icelandic: Ifirmasta tilheyrir flokki lyfja sem þekktur er sem angíótensín-II blokkar.
English: In patients with high blood pressure and type 2 diabetes with renal disease, dizziness when getting up from a lying or sitting position, low blood pressure when getting up from a lying or sitting position, pain in joints or muscles and decreased levels of a protein in the red blood cells (haemoglobin) were also reported.
Icelandic: Hjá sjúklingum með háþrýsting og sykursýki af gerð 2 ásamt nýrnasjúkdómi var einnig greint frá sundli þegar staðið er upp frá útafliggjandi eða sitjandi stöðu, lágþrýstingi þegar staðið er upp frá útafliggjandi eða sitjandi stöðu, verkjum í liðum eða vöðvum og lækkuðum gildum póteins í rauðum blóðkornum.
English: In particular, the addition of a diuretic such as hydrochlorothiazide has been shown to have an additive effect with Ifirmasta (see section 4.5).
Icelandic: Sérstaklega má nefna að með því að gefa þvagræsilyf, t.d. hýdróklórtíazíð, að auki með Ifirmasta fæst samanlögð verkun beggja lyfja (sjá kafla 4.5).
English: In patients whose vascular tone and renal function depend predominantly on the activity of the reninangiotensin-aldosterone system (e.g. patients with severe congestive heart failure or underlying renal disease, including renal artery stenosis), treatment with angiotensin converting enzyme inhibitors or angiotensin-II receptor antagonists that affect this system has been associated with acute hypotension, azotaemia, oliguria, or rarely acute renal failure (see section 4.5).
Icelandic: Hjá sjúklingum, þar sem æðaþan (vascular tone) og nýrnastarfsemi eru aðallega háð virkni renínangíótensín-aldósterónkerfisins (t.d. sjúklingum með alvarlega hjartabilun eða undirliggjandi nýrnasjúkdóm, þar með töldum nýrnaslagæðarþrengslum), hefur meðferð með ACE-hemlum eða angíótensín-II blokkum sem hafa áhrif á þetta kerfi verið tengd bráðum lágþrýstingi, aukningu köfnunarefnis í blóði, þvagþurrð og í örfáum tilvikum bráðri nýrnabilun (sjá kafla 4.5).
English: AngiotensinII is a substance produced in the body which binds to receptors in blood vessels causing them to tighten.
Icelandic: Angíótensín-II er efni sem framleitt er í líkamanum, það binst viðtökum í æðum og veldur þrengingu þeirra.
English: Ifirmasta is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Icelandic: Ifirmasta snemma á meðgöngu og það má alls ekki þegar liðnir eru meira en 3 mánuðir af meðgöngunni þar sem notkun lyfsins á þeim tíma getur haft alvarlegar afleiðingar fyrir barnið.
English: Ifirmasta is used in adult patients - to treat high blood pressure (essential hypertension) - to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.
Icelandic: Ifirmasta er notað handa fullorðnum sjúklingum - til meðferðar á of háum blóðþrýstingi (háþrýstingi) - til að hlífa nýrum hjá sjúklingum með háþrýsting, sykursýki af gerð 2 og þegar niðurstöður rannsókna gefa vísbendingu um skerta nýrnastarfsemi.
English: Ifirmasta at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.
Icelandic: Með því að gefa 150 mg skammt af Ifirmasta einu sinni á sólarhring næst betri sólarhringsstjórn á blóðþrýstingi en með 75 mg skammti.
English: hypersensitivity reactions such as angioedema, rash, urticaria, anaphylactic reaction, anaphylactic shock
Icelandic: Ofnæmisviðbrögð eins og ofsabjúgur, útbrot, ofsakláði, bráðaofnæmisviðbrögð, bráðaofnæmislost
English: What Ifirmasta contains - The active substance is irbesartan.
Icelandic: - Virka innihaldsefnið er irbesartan.
English: 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 56x1 film-coated tablets 84 film-coated tablets 90 film-coated tablets 98 film-coated tablets
Icelandic: 84 filmuhúðaðar töflur 90 filmuhúðaðar töflur 98 filmuhúðaðar töflur
English: The decrease in blood pressure is dose-related for once a day doses with a tendency towards plateau at doses above 300 mg. Doses of 150-300 mg once daily lower supine or seated blood pressures at trough (i.e. 24 hours after dosing) by an average of 8-13/5-8 mm Hg (systolic/diastolic) greater than those associated with placebo.
Icelandic: 150-300 mg skammtar gefnir einu sinni á sólarhring lækka blóðþrýsting bæði í útafliggjandi og sitjandi stöðu við lægsta blóðgildi (þ.e. 24 klst. eftir skömmtun) að meðaltali um 8-13/5-8 mmHg (slagbils/þanbils) meira en hjá þeim sem fengu lyfleysu.
English: If a child swallows some tablets, contact your doctor immediately.
Icelandic: Hafðu samstundis samband við lækni ef barn gleymir töflur.
English: Talk to your doctor or pharmacist before taking Ifirmasta and if any of the following apply to you: - if you get excessive vomiting or diarrhoea, - if you suffer from kidney problems, - if you suffer from heart problems, - if you receive Ifirmasta for diabetic kidney disease.
Icelandic: - ef þú færð mikil uppköst eða niðurgang, - ef þú ert með nýrnasjúkdóm, - ef þú ert með hjartasjúkdóm, - ef þú færð Ifirmasta við nýrnasjúkdómi af völdum sykursýki.
English: Because no information is available regarding the use of Ifirmasta during breast-feeding, Ifirmasta is not recommended and alternative treatments with better established safety profiles during breastfeeding are preferable, especially while nursing a newborn or preterm infant.
Icelandic: Þar sem engar upplýsingar liggja fyrir um notkun Ifirmasta meðan á brjóstagjöf stendur er ekki mælt með notkun Ifirmasta hjá konum sem hafa barn á brjósti.
English: The most likely manifestations of overdosage are expected to be hypotension and tachycardia; bradycardia might also occur from overdose.
Icelandic: Líklegustu einkenni ofskömmtunar eru talin vera lágþrýstingur og hraðtaktur; hægur hjartsláttur getur einnig komið fram vegna ofskömmtunar.
English: - Common (may affect up to 1 in 10 people): dizziness, feeling sick/vomiting, and fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme).
Icelandic: Svimi, ógleði/uppköst, þreyta og hækkuð blóðgildi ensíms, sem mælir starfsemi vöðva og hjarta (kreatínkínasaensím).
English: In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function, - if you are going to have an operation (surgery) or be given anaesthetics,
Icelandic: Ef svo er getur verið að læknirinn geri blóðmælingar reglulega, sérstaklega til að mæla kalíumþéttni í blóði ef nýrnastarfsemi er skert, - ef þú ætlar að gangast undir skurðaðgerð eða verður svæfð(ur), skaltu einnig segja lækninum frá því, - ef þú notar eitthvert af eftirtöldum lyfjum sem notuð eru til að meðhöndla háan blóðþrýsting:
English: When angiotensin II antagonists are administered simultaneously with non-steroidal antiinflammatory medicinal products (i.e. selective COX-2 inhibitors, acetylsalicylic acid (> 3 g/day) and non-selective NSAIDs), attenuation of the antihypertensive effect may occur.
Icelandic: II blokkar eru gefnir samtímis bólgueyðandi gigtarlyfjum (t.d. sértækum COX-2 hemlum, asetýlsalicýlsýru (> 3 g/sólarhring) og ósértækum bólgueyðandi gigtarlyfjum) getur dregið úr blóðþrýstingslækkandi áhrifum.
English: Potassium supplements and potassium-sparing diuretics:
Icelandic: Kalíumuppbót og kalíumsparandi þvagræsilyf:
English: Ifirmasta 75 mg film-coated tablets
Icelandic: Ifirmasta 75 mg filmuhúðaðar töflur
English: What Ifirmasta looks like and contents of the pack Ifirmasta 75 mg film-coated tablets are: white, oval film-coated tablets.
Icelandic: Lýsing á útliti Ifirmasta og pakkningastærðir Ifirmasta 75 mg filmuhúðaðar töflur eru: hvítar sporöskjulaga filmuhúðaðar töflur.
English: Ear and labyrinth disorder: Not known:
Icelandic: Eyru og völundarhús:
English: See section 4.
Icelandic: C09CA04.
English: The dose may later be increased to 300 mg once daily depending on blood pressure response.
Icelandic: Skammtinn má síðar auka í 300 mg einu sinni á sólarhring háð svörun blóðþrýstingsins.
English: Diuretics and other antihypertensive agents:
Icelandic: Þvagræsilyf og önnur blóðþrýstingslækkandi lyf:
English: Skin and subcutaneous tissue disorders: Not known:
Icelandic: Húð og undirhúð:
English: The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response.
Icelandic: Skammtinn má síðar auka í 300 mg (fjórar töflur á dag) einu sinni á sólarhring háð svörun blóðþrýstingsins.
English: What Ifirmasta looks like and contents of the pack Ifirmasta 300 mg film-coated tablets are: white, oval film-coated tablets.
Icelandic: Lýsing á útliti Ifirmasta og pakkningastærðir Ifirmasta 300 mg filmuhúðaðar töflur eru: hvítar sporöskjulaga filmuhúðaðar töflur.
English: In patients not adequately controlled by irbesartan alone, the addition of a low dose of hydrochlorothiazide (12.5 mg) to irbesartan once daily results in a further placebo-adjusted blood pressure reduction at trough of 7-10/3-6 mm Hg (systolic/diastolic).
Icelandic: Hjá sjúklingum, þar sem ekki tekst að stjórna blóðþrýstingi á viðeigandi hátt með irbesartani eingöngu, verður, frekari blóðþrýstingslækkun um 7-10/3-6 mmHg (slagbils/þanbils) ef litlum skammti af hýdróklórtíazíði (12,5 mg) er bætt við gjöf irbesartani einu sinni á sólarhring.
English: vertigo, headache
Icelandic: Blóð og eitlar
English: What Ifirmasta looks like and contents of the pack Ifirmasta 150 mg film-coated tablets are: white, oval film-coated tablets.
Icelandic: Lýsing á útliti Ifirmasta og pakkningastærðir Ifirmasta 150 mg filmuhúðaðar töflur eru: hvítar sporöskjulaga filmuhúðaðar töflur.
English: Ifirmasta 300 mg film-coated tablets
Icelandic: Ifirmasta 300 mg filmuhúðaðar töflur
English: Other medicines and Ifirmasta
Icelandic: Notkun annarra lyfja samhliða Ifirmasta
English: No dose adjustment is necessary in patients with mild to moderate hepatic impairment.
Icelandic: Ekki er nauðsynlegt að breyta skömmtum hjá sjúklingum með væga eða í meðallagi skerta lifrarstarfsemi.
English: The dose may later be increased to 300 mg (two tablets a day) once daily depending on blood pressure response.
Icelandic: Skammtinn má síðar auka í 300 mg (tvær töflur á dag) einu sinni á sólarhring háð svörun blóðþrýstingsins.
English: Ifirmasta 150 mg film-coated tablets
Icelandic: Ifirmasta 150 mg filmuhúðaðar töflur
English: Each film-coated tablet contains 75 mg irbesartan (as hydrochloride).
Icelandic: Hver filmuhúðuð tafla inniheldur 75 mg af irbesartani (sem hýdróklóríð).
English: The demonstration of renal benefit of Ifirmasta in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Icelandic: Þetta byggist á rannsóknum þar sem irbesartan var notað með öðrum háþrýstingslyfjum eftir þörfum til þess að ná markblóðþrýstingi (sjá kafla 4.3, 4.4, 4.5 og 5.1).
English: Steady state plasma concentrations are attained within 3 days after initiation of a once-daily dosing regimen.Limited accumulation of irbesartan (< 20%) is observed in plasma upon repeated once-daily dosing.
Icelandic: Takmarkað magn irbesartans safnast upp í plasma (< 20%) við endurtekna gjöf einu sinni á sólarhring.
English: Ifirmasta 300 mg film-coated tablets Each film-coated tablet contains 16 mg castor oil.
Icelandic: Hver filmuhúðuð tafla inniheldur 16 mg af laxerolíu.
English: Aortic and mitral valve stenosis, obstructive hypertrophic cardiomyopathy As with other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
Icelandic: Ósæðar- og míturlokuþrengsli, ofvaxtarhjartavöðvakvilli með teppu (obstructive hypertrophic cardiomyopathy)
English: Each film-coated tablet contains 300 mg irbesartan (as hydrochloride).
Icelandic: Hver filmuhúðuð tafla inniheldur 300 mg af irbesartani (sem hýdróklóríð).
English: Hyperkalemia
Icelandic: KRKA Pharma
English: The “Irbesartan Diabetic Nephropathy Trial (IDNT)” shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria.
Icelandic: Trial, IDNT) sýndi fram á að irbesartan hægir á framrás nýrnasjúkdóms hjá sjúklingum með langvarandi skerta nýrnastarfsemi og mikla próteinmigu.
English: - Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg (two tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Icelandic: - Sjúklingar með háþrýsting og sykursýki gerð 2 með nýrnasjúkdómi Hjá sjúklingum með háan blóðþrýsting og sykursýki af gerð 2 eru 300 mg (tvær töflur á dag) einu sinni á sólarhring ráðlagður viðhaldsskammtur við meðferð á tengdum nýrnasjúkdómi.
English: The frequency of the side effects listed below is defined using the following convention: Very common: may affect more than 1 in 10 people Common: may affect up to 1 in 10 people
Icelandic: - Mjög algengar (geta komið fyrir hjá fleiri en 1 af hverjum 10 einstaklingum):
English: 56 x 1 tablets: EU/1/08/480/010 84 tablets: EU/1/08/480/011
Icelandic: EU/1/08/480/010 84 filmuhúðaðar töflur:
English: - Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg (four tablets a day) once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Icelandic: - Sjúklingar með háþrýsting og sykursýki gerð 2 með nýrnasjúkdómi Hjá sjúklingum með háan blóðþrýsting og sykursýki af gerð 2 eru 300 mg (fjórar töflur) einu sinni á sólarhring ráðlagður viðhaldsskammtur við meðferð á tengdum nýrnasjúkdómi.
English: Ifirmasta 150 mg film-coated tablets Each film-coated tablet contains 8 mg castor oil.
Icelandic: Hver filmuhúðuð tafla inniheldur 8 mg af laxerolíu.
English: musculoskeletal pain*
Icelandic: Stoðkerfisverkir*
English: 56 x 1 tablets: EU/1/08/480/016 84 tablets: EU/1/08/480/017
Icelandic: EU/1/08/480/016 84 filmuhúðaðar töflur:
English: Each film-coated tablet contains 150 mg irbesartan (as hydrochloride).
Icelandic: Hver filmuhúðuð tafla inniheldur 150 mg af irbesartani (sem hýdróklóríð).
English: - Patients with high blood pressure and type 2 diabetes with kidney disease In patients with high blood pressure and type 2 diabetes, 300 mg once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Icelandic: - Sjúklingar með háþrýsting og sykursýki gerð 2 með nýrnasjúkdómi Hjá sjúklingum með háan blóðþrýsting og sykursýki af gerð 2 eru 300 mg einu sinni á sólarhring ráðlagður viðhaldsskammtur við meðferð á tengdum nýrnasjúkdómi.
English: Rreversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Icelandic: Við samtímis gjöf litíums og ACE-hemla hefur orðið vart hækkunar á litíumgildum í sermi, sem gekk til baka og eiturverkana.
English: When Ifirmasta is used in patients with impaired renal function, a periodic monitoring of potassium and creatinine serum levels is recommended.
Icelandic: Mælt er með að mæla kalíum- og kreatíníngildi í sermi reglulega, þegar Ifirmasta er notað hjá sjúklingum með skerta nýrnastarfsemi.
English: 56 tablets: EU/1/08/480/009
Icelandic: EU/1/08/480/006
English: dizziness, orthostatic dizziness*
Icelandic: Sundl, réttstöðusundl*
English: Ifirmasta 150 mg film-coated tablets Each film-coated tablet contains 150 mg irbesartan (as hydrochloride).
Icelandic: Hver filmuhúðuð tafla inniheldur150 mg af irbesartani (sem hýdróklóríð).
English: Ifirmasta 150 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Icelandic: Ifirmasta 150 mg filmuhúðaðar töflur: fást í öskjum sem innihalda 14, 28, 30, 56, 84, 90 og 98
English: What you need to know before you take Ifirmasta
Icelandic: Áður en byrjað er að nota Ifirmasta
English: Ifirmasta 75 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Icelandic: Ifirmasta 75 mg filmuhúðaðar töflur: fást í öskjum sem innihalda 14, 28, 30, 56, 84, 90 og 98
English: Ifirmasta 300 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Icelandic: 14, 28, 30, 56, 84, 90 eða 98 filmuhúðaðar töflur í öskju eru fáanlegar.
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS) There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure).
Icelandic: Vísbendingar eru um að samhliðanotkun ACE-hemla, angíótensín II viðtakablokka eða aliskirens auki hættu á blóðþrýstingslækkun, blóðkalíumhækkun og skerðingu á nýrnastarfsemi (þ.m.t. bráðri nýrnabilun).
English: 98 tablets: EU/1/08/480/012
Icelandic: EU/1/08/480/012
English: Blister (PVC/PE/PVDC/Alu): 56 x 1 film-coated tablets in perforated unit dose blisters in box.
Icelandic: filmuhúðaðar töflur í þynnupakkningum og í öskjum sem innihalda 56 x 1 filmuhúðuð tafla í gataðri stakskammta þynnupakkningu.
English: Renal impairment and kidney transplantation
Icelandic: Niðurgangur, meltingartruflanir/brjóstsviði
English: 98 tablets: EU/1/08/480/018
Icelandic: EU/1/08/480/018
English: Mechanism of action:
Icelandic: Meltingarfæri:
English: 90 tablets: EU/1/08/480/024
Icelandic: EU/1/08/480/020
English: - Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.
Icelandic: Aukin hjartsláttartíðni, andlitsroði, hósti, niðurgangur, meltingartruflanir/nábítur, truflanir á kyngetu og verkur fyrir brjósti.
English: Nervous system disorders: Common:
Icelandic: Hjarta: Sjaldgæfar:
English: 14 tablets: EU/1/08/480/007 28 tablets: EU/1/08/480/008 30 tablets: EU/1/08/480/021 56 tablets: EU/1/08/480/009 56 x 1 tablets: EU/1/08/480/010 84 tablets: EU/1/08/480/011 90 tablets: EU/1/08/480/022 98 tablets: EU/1/08/480/012
Icelandic: EU/1/08/480/009 56 x 1 filmuhúðuð tafla:
English: 14 tablets: EU/1/08/480/001 28 tablets: EU/1/08/480/002 30 tablets: EU/1/08/480/019 56 tablets: EU/1/08/480/003 56 x 1 tablets: EU/1/08/480/004 84 tablets: EU/1/08/480/005 90 tablets: EU/1/08/480/020 98 tablets: EU/1/08/480/006
Icelandic: EU/1/08/480/003 56 x 1 filmuhúðuð tafla:
English: There is no experience regarding the administration of Ifirmasta in patients with a recent kidney transplantation.
Icelandic: Ifirmasta hjá sjúklingum sem nýlega hafa gengist undir nýrnaígræðslu.
English: - Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Icelandic: Ef þú ert með háþrýsting og sykursýki af gerð 2 með nýrnasjúkdómi geta blóðsýni mælst með of hátt kalíumgildi.
English: Immune system disorders: Not known:
Icelandic: Hjálparefni með þekkta verkun:
English: Blister (PVC/PE/PVDC/Alu): 14, 28, 30, 56, 84, 90 or 98 film-coated tablets in box are available.
Icelandic: Ifirmasta 300 mg filmuhúðaðar töflur: fást í öskjum sem innihalda 14, 28, 30, 56, 84, 90 og 98
English: Vocate φαρμακευτικη αε
Icelandic: Grikkland Vocate φαρμακευτικη αε
English: Deutsche Bundeswehr Kommando Sanitätsdienst der Bundeswehr
Icelandic: Þýskaland Deutsche Bundeswehr Kommando Sanitätsdienst der Bundeswehr
English: A C T I R A
Icelandic: T I R A
English: Teva Gyógyszergyár Zrt
Icelandic: Ungverjaland Teva Gyógyszergyár Zrt
English: Iip - Institut Für Industrielle Pharmazie Forschungs- Und Entwicklungsgesellschaft Mbh
Icelandic: Þýskaland Iip - Institut Für Industrielle Pharmazie Forschungs- Und Entwicklungsgesellschaft Mbh
English: Zydus France
Icelandic: Frakkland Zydus France
English: Fresenius Kabi Hungary Kft.
Icelandic: Ungverjaland Fresenius Kabi Hungary Kft.
English: INN/Active substance + Strength
Icelandic: INN/virkt efni + styrkleiki
English: Tecnimede - Sociedade TécnicoMedicinal, Sa
Icelandic: Tecnimede - Sociedade Técnico-Medicinal, Sa
English: Accord Healthcare France Sas Levofloxacine Accord Healthcare
Icelandic: Frakkland Accord Healthcare France Sas Levofloxacine Accord Healthcare